Oramed Pharmaceuticals Inc. (ORMP) Financials

$2.12

$0.12 (-5.36%)
Last update: 04:00 PM EST
Day's range
$2.12
Day's range
$2.23
$10M$10M$0$0-$10M-$10M-$20M-$20M-$30M-$30M-$40M-$40MEarning201720172018201820192019202020202021202120222022202320231000%1000%500%500%0%0%-500%-500%-1000%-1000%-1500%-1500%Profit Margin
Profit Margin
Revenue
Earnings

ORMP Income statement / Annual

Last year (2023), Oramed Pharmaceuticals Inc.'s total revenue was $1.34 M, a decrease of 50.43% from the previous year. In 2023, Oramed Pharmaceuticals Inc.'s net income was $5.53 M. See Oramed Pharmaceuticals Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 08/31/2021 08/31/2020 08/31/2019 08/31/2018 08/31/2017 08/31/2016 08/31/2015 08/31/2014
Operating Revenue $1.34 M $2.70 M $2.70 M $2.71 M $2.70 M $2.45 M $2.46 M $641.00 K $0.00 $0.00
Cost of Revenue $0.00 $0.00 $0.00 $90.00 K $90.00 K $86.00 K $187.00 K $490.00 K $0.00 $0.00
Gross Profit $1.34 M $2.70 M $2.70 M $2.62 M $2.61 M $2.36 M $2.27 M $151.00 K $0.00 $0.00
Gross Profit Ratio 1 1 1 0.97 0.97 0.96 0.92 0.24 0 0
Research and Development Expenses $8.97 M $27.64 M $20.99 M $10.24 M $13.52 M $11.98 M $10.28 M $7.71 M $4.78 M $3.28 M
General & Administrative Expenses $8.43 M $13.81 M $5.94 M $4.23 M $3.72 M $4.08 M $2.76 M $2.45 M $2.60 M $2.63 M
Selling & Marketing Expenses -$287.00 K $1.85 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $8.14 M $15.66 M $5.94 M $4.23 M $3.72 M $4.08 M $2.76 M $2.45 M $2.60 M $2.63 M
Other Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $17.11 M $43.30 M $26.93 M $14.47 M $17.24 M $16.06 M $13.04 M $10.16 M $7.38 M $5.91 M
Cost And Expenses $17.11 M $43.30 M $26.93 M $14.47 M $17.33 M $15.98 M $13.23 M $10.65 M $7.38 M $5.91 M
Interest Income $8.03 M $3.57 M $347.00 K $690.00 K $1.06 M $903.00 K $785.00 K $474.00 K $168.00 K $225.00 K
Interest Expense $3.58 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $11.00 K
Depreciation & Amortization $196.00 K $3.62 M $77.00 K $7.00 K $8.00 K $6.00 K $5.00 K $4.00 K $4.00 K $6.00 K
EBITDA -$15.57 M -$36.98 M -$25.04 M -$11.31 M -$14.17 M -$13.49 M -$10.76 M -$9.99 M -$7.38 M -$5.68 M
EBITDA Ratio -11.62 -13.68 -9.26 -4.17 -5.24 -5.51 -4.38 -15.58 0 0
Operating Income Ratio -11.77 -15.02 -8.96 -4.34 -5.41 -5.52 -4.39 -15.62 0 0
Total Other Income/Expenses Net $20.86 M $2.93 M $893.00 K -$438.00 K -$450.00 K -$30.00 K -$10.00 K -$17.00 K -$3.00 K $214.00 K
Income Before Tax $5.09 M -$37.66 M -$22.99 M -$11.51 M -$14.06 M -$12.73 M -$10.08 M -$9.63 M -$7.23 M -$5.69 M
Income Before Tax Ratio 3.8 -13.93 -8.5 -4.25 -5.2 -5.2 -4.1 -15.02 0 0
Income Tax Expense $0.00 $100.00 K -$2.88 M $192.00 K $300.00 K -$800.00 K $400.00 K $1.34 M -$1.00 K $4.00 K
Net Income $5.53 M -$37.76 M -$22.24 M -$11.51 M -$14.36 M -$12.73 M -$10.48 M -$10.96 M -$7.23 M -$5.70 M
Net Income Ratio 4.12 -13.97 -8.23 -4.25 -5.31 -5.2 -4.27 -17.1 0 0
EPS 0.14 -0.97 -0.78 -0.56 -0.82 -0.86 -0.79 -0.87 -0.67 -0.62
EPS Diluted 0.14 -0.97 -0.78 -0.56 -0.82 -0.86 -0.79 -0.87 -0.67 -0.62
Weighted Average Shares Out $40.32 M $39.00 M $28.47 M $20.53 M $17.45 M $14.88 M $13.31 M $12.62 M $10.82 M $9.24 M
Weighted Average Shares Out Diluted $40.57 M $39.00 M $28.47 M $20.53 M $17.45 M $14.88 M $13.31 M $12.62 M $10.82 M $9.24 M
Link